A device developed by a Georgia Tech biomedical engineering professor that uses artificial intelligence (AI) to improve the treatment process for those with structural heart disease received FDA clearance in June.
Precision TAVI is an (AI)-driven individualized computer predictive modeling tool that can be used to improve patient outcomes, enhanced lifetime planning, and reduced costs associated with treating those needing transcatheter aortic valve replacement.
Lakshmi (Prasad) Dasi, a professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech, is the founder and chief technology officer for Dasi Simulations, the company behind the Precision TAVI.
“DASI Simulations empowers every heart team with critical insights guaranteeing the identification of the best possible care for individual patients, customized to their unique circumstances and anatomy, Dasi said. “One surgery at a time, our technology helps avoid complications, repeated interventions, helps lifelong planning for optimal structural heart care, and has the potential to save billions in unnecessary costs from preventable complications.”
Latest BME News
Coskun pioneering new research area and building a company around iseqPLA technology
BME researcher Ankur Singh using new technology to uncover weakened response in cancer patients
Research team led by BME's Cheng Zhu probes the underlying mechanisms of PD-1 checkpoint inhibitor therapy
Georgia Tech grad reflects on his rookie season as a biomechanics engineer with the New York Mets
First-year students learned about the resources and support they could access during their college journey in BME.
BME assistant professor using Sloan Scholars Mentoring Network seed grant to support her lab's work
Coulter Department honors Jaydev Desai, Melissa Kemp, Gabe Kwong, and Johnna Temenoff